Form 4: Acadia Healthcare CEO Disposes of Shares for Tax Obligations

Sentiment:

Insider Transaction Report


Acadia Healthcare Company, Inc. CEO Christopher H. Hunter reported the disposition of 5,464 shares of common stock on June 26, 2025, at $20.94 per share, primarily to satisfy tax withholding obligations.

Summary

  • Christopher H. Hunter, who serves as both Director and Chief Executive Officer of Acadia Healthcare Company, Inc. (ACHC), reported a transaction on June 26, 2025.
  • The transaction involved the disposition of 5,464 shares of Acadia Healthcare common stock.
  • The shares were disposed of at a price of $20.94 per share.
  • This disposition was coded as 'F', indicating it was a transaction with the issuer to satisfy tax withholding obligations.
  • Following this reported transaction, Mr. Hunter beneficially owns 258,530 shares of Acadia Healthcare common stock.
  • The transaction was made pursuant to a Rule 10b5-1(c) plan, which provides an affirmative defense against insider trading allegations.

Sentiment

Score: 5

Explanation: The document reports a routine, non-discretionary transaction (disposition for tax withholding) by an insider, which is neutral in sentiment and does not indicate any positive or negative operational or strategic developments for the company.

Future Outlook

This Form 4 filing reports a routine insider transaction for tax purposes and does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing is a standard SEC Form 4, reporting a change in beneficial ownership by an insider. Such transactions, particularly those for tax withholding purposes, are common and routine for executives who receive equity compensation. They typically do not reflect a change in management's sentiment about the company's prospects but rather a necessary financial event related to compensation.

Stakeholder Impact

  • Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes by an executive, not indicative of a change in investment sentiment.
  • Employees: No direct impact.

Key Dates

DateDescription
06/26/2025Date of transaction (disposition of common stock by Christopher H. Hunter).
06/27/2025Date the Form 4 filing was signed by Brian Farley as Attorney in Fact for Christopher H. Hunter.

Keywords

Acadia Healthcare, ACHC, Form 4, Insider Transaction, Stock Disposition, Christopher H. Hunter, CEO, Tax Withholding, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.